Placebo control, double blind, randomized clinical trial to assess the effecacy of Ulinastatin for postoperative incidence rate of complications following pancreaticoduodenectomy
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Ulinastatin (Primary)
- Indications Pancreatitis
- Focus Adverse reactions
- 23 Feb 2017 New source identified and integrated (ChiCTR-TRC-12002160 Chinese Clinical Trial Register).
- 23 Feb 2017 New trial record